US Stock MarketDetailed Quotes

NRX Pharmaceuticals (NRXP)

Watchlist
  • 2.510
  • -0.010-0.40%
Close Apr 16 15:59 ET
83.00MMarket Cap-1.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NRX Pharmaceuticals (NRXP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
1.23M
983K
242K
0
0
0
0
0
0
0
Operating revenue
--1.23M
--983K
--242K
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
505K
408K
97K
0
Gross profit
720K
575K
145K
0
Operating expense
-8.42%16.94M
113.77%5.2M
37.95%4.17M
-47.09%3.73M
-37.53%3.75M
-32.93%18.5M
-41.48%2.43M
-47.97%3.02M
-11.19%7.05M
-36.43%6M
Selling and administrative expenses
-3.25%13.06M
75.93%4.57M
16.56%2.81M
-35.40%2.74M
-30.75%2.94M
-5.04%13.5M
38.73%2.6M
-3.41%2.41M
4.45%4.25M
-26.53%4.25M
-General and administrative expense
-3.25%13.06M
----
----
-35.40%2.74M
-30.75%2.94M
-5.04%13.5M
38.78%2.6M
-3.33%2.41M
4.45%4.25M
-26.53%4.25M
Research and development costs
-39.07%3.78M
-46.14%558K
133.88%1.43M
-64.80%987K
-54.00%804K
-53.64%6.2M
-59.12%1.04M
-81.56%611K
-27.60%2.8M
-52.11%1.75M
Depreciation amortization depletion
1,300.00%70K
4,100.00%42K
1,200.00%26K
----
----
--5K
--1K
--2K
----
----
-Depreciation and amortization
1,300.00%70K
4,100.00%42K
1,200.00%26K
----
----
--5K
--1K
--2K
----
----
Other operating expenses
103.00%36K
--30K
---94K
----
----
-580.80%-1.2M
----
----
----
----
Operating profit
12.31%-16.22M
-90.13%-4.62M
-33.16%-4.02M
47.09%-3.73M
37.53%-3.75M
32.93%-18.5M
41.48%-2.43M
47.97%-3.02M
11.19%-7.05M
36.43%-6M
Net non-operating interest income expense
-254.30%-659K
-16,775.00%-667K
-66.67%2K
-71.43%2K
101.97%4K
-149.73%-186K
166.67%4K
-92.41%6K
-95.17%7K
-230.13%-203K
Non-operating interest income
-72.73%12K
0.00%4K
-66.67%2K
-71.43%2K
-85.19%4K
-91.09%44K
-94.59%4K
-94.96%6K
-95.17%7K
-82.69%27K
Non-operating interest expense
191.74%671K
--671K
--0
--0
--0
91.67%230K
--0
--0
--0
--230K
Other net income (expense)
-82.34%-11.74M
184.98%5.65M
-234.10%-1.87M
-1,522.13%-13.85M
-440.98%-1.77M
-119.20%-6.44M
-3,811.76%-6.65M
518.32%1.39M
7.58%-854K
81.42%-327K
Gain on sale of security
49.67%-834K
294.16%3.56M
146.06%406K
-35,733.33%-6.41M
18,088.89%1.62M
-8,385.00%-1.66M
-26,057.14%-1.83M
534.62%165K
263.64%18K
-175.00%-9K
Earnings from equity interest
---35K
----
----
----
----
----
----
----
----
----
Special income (charges)
----
----
-507.87%-772K
--0
---100K
----
----
---127K
--0
--0
-Less:Other special charges
----
----
507.87%772K
----
--100K
----
----
--127K
----
----
Other non- operating income (expenses)
-127.36%-10.87M
57.38%-2.11M
-210.85%-1.5M
-753.10%-7.44M
-933.96%-3.29M
-76.62%-4.78M
-5,785.06%-4.95M
477.44%1.36M
-31.52%-872K
82.05%-318K
Income before tax
-13.91%-28.62M
103.97%360K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
Income tax
Net income
-13.91%-28.62M
103.97%360K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
Net income continuous Operations
-13.91%-28.62M
103.97%360K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
Minority interest income
Net income attributable to the parent company
-13.91%-28.62M
103.97%360K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
Preferred stock dividends
Other preferred stock dividends
0
Net income attributable to common stockholders
-13.91%-28.62M
103.97%360K
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.69%-25.13M
-109.12%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
Basic earnings per share
43.22%-1.34
125.97%0.2
-80.00%-0.27
-30.67%-0.98
54.05%-0.34
40.70%-2.36
-54.00%-0.77
79.73%-0.15
38.02%-0.75
55.42%-0.74
Diluted earnings per share
43.22%-1.34
125.97%0.2
-80.00%-0.27
-30.67%-0.98
54.05%-0.34
40.70%-2.36
-54.00%-0.77
79.73%-0.15
38.02%-0.75
55.42%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 1.23M983K242K0000000
Operating revenue --1.23M--983K--242K--0--0--0--0--0--0--0
Cost of revenue 505K408K97K0
Gross profit 720K575K145K0
Operating expense -8.42%16.94M113.77%5.2M37.95%4.17M-47.09%3.73M-37.53%3.75M-32.93%18.5M-41.48%2.43M-47.97%3.02M-11.19%7.05M-36.43%6M
Selling and administrative expenses -3.25%13.06M75.93%4.57M16.56%2.81M-35.40%2.74M-30.75%2.94M-5.04%13.5M38.73%2.6M-3.41%2.41M4.45%4.25M-26.53%4.25M
-General and administrative expense -3.25%13.06M---------35.40%2.74M-30.75%2.94M-5.04%13.5M38.78%2.6M-3.33%2.41M4.45%4.25M-26.53%4.25M
Research and development costs -39.07%3.78M-46.14%558K133.88%1.43M-64.80%987K-54.00%804K-53.64%6.2M-59.12%1.04M-81.56%611K-27.60%2.8M-52.11%1.75M
Depreciation amortization depletion 1,300.00%70K4,100.00%42K1,200.00%26K----------5K--1K--2K--------
-Depreciation and amortization 1,300.00%70K4,100.00%42K1,200.00%26K----------5K--1K--2K--------
Other operating expenses 103.00%36K--30K---94K---------580.80%-1.2M----------------
Operating profit 12.31%-16.22M-90.13%-4.62M-33.16%-4.02M47.09%-3.73M37.53%-3.75M32.93%-18.5M41.48%-2.43M47.97%-3.02M11.19%-7.05M36.43%-6M
Net non-operating interest income expense -254.30%-659K-16,775.00%-667K-66.67%2K-71.43%2K101.97%4K-149.73%-186K166.67%4K-92.41%6K-95.17%7K-230.13%-203K
Non-operating interest income -72.73%12K0.00%4K-66.67%2K-71.43%2K-85.19%4K-91.09%44K-94.59%4K-94.96%6K-95.17%7K-82.69%27K
Non-operating interest expense 191.74%671K--671K--0--0--091.67%230K--0--0--0--230K
Other net income (expense) -82.34%-11.74M184.98%5.65M-234.10%-1.87M-1,522.13%-13.85M-440.98%-1.77M-119.20%-6.44M-3,811.76%-6.65M518.32%1.39M7.58%-854K81.42%-327K
Gain on sale of security 49.67%-834K294.16%3.56M146.06%406K-35,733.33%-6.41M18,088.89%1.62M-8,385.00%-1.66M-26,057.14%-1.83M534.62%165K263.64%18K-175.00%-9K
Earnings from equity interest ---35K------------------------------------
Special income (charges) ---------507.87%-772K--0---100K-----------127K--0--0
-Less:Other special charges --------507.87%772K------100K----------127K--------
Other non- operating income (expenses) -127.36%-10.87M57.38%-2.11M-210.85%-1.5M-753.10%-7.44M-933.96%-3.29M-76.62%-4.78M-5,785.06%-4.95M477.44%1.36M-31.52%-872K82.05%-318K
Income before tax -13.91%-28.62M103.97%360K-262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M
Income tax
Net income -13.91%-28.62M103.97%360K-262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M
Net income continuous Operations -13.91%-28.62M103.97%360K-262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M
Minority interest income
Net income attributable to the parent company -13.91%-28.62M103.97%360K-262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M
Preferred stock dividends
Other preferred stock dividends 0
Net income attributable to common stockholders -13.91%-28.62M103.97%360K-262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.69%-25.13M-109.12%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M
Basic earnings per share 43.22%-1.34125.97%0.2-80.00%-0.27-30.67%-0.9854.05%-0.3440.70%-2.36-54.00%-0.7779.73%-0.1538.02%-0.7555.42%-0.74
Diluted earnings per share 43.22%-1.34125.97%0.2-80.00%-0.27-30.67%-0.9854.05%-0.3440.70%-2.36-54.00%-0.7779.73%-0.1538.02%-0.7555.42%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -